Fluoxetine induces the transcription of genes encoding c-fos, corticotropin-releasing factor and its type 1 receptor in rat brain

Neuroscience

Volumn 87, Issue 2, 1998, Pages 463-477

  Torres, G ^a   Horowitz, J M ^a   Laflamme, N ^b   Rivest, S ^b  

^a UNIVERSITY AT BUFFALO   (United States)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Depression; Gene expression; Hypothalamic pituitary adrenal axis; Paraventricular nucleus; Serotonin; Sex differences

Indexed keywords

ANTIDEPRESSANT AGENT; CORTICOTROPIN RELEASING FACTOR RECEPTOR; FLUOXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; GENETIC TRANSCRIPTION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MENTAL DISEASE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RAT; SEROTONINERGIC TRANSMISSION; SEX DIFFERENCE; THALAMUS MIDLINE NUCLEUS;

ANIMALS; BRAIN CHEMISTRY; CORTICOTROPIN-RELEASING HORMONE; FEMALE; FLUOXETINE; GENES, FOS; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA PROBES; RNA, MESSENGER; SEROTONIN UPTAKE INHIBITORS; SEX CHARACTERISTICS; TRANSCRIPTION, GENETIC;

EID: 0032551688     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00147-X     Document Type: Article

References (51)

1. Aarmario A., Garcia-Marquez C. Tricyclic antidepressants activate the pituitary-adrenal axis in the rat. Tolerance to repeated drug administration. Eur. J. Pharmac. 140:1987;239-244.
2. Adolphs R., Tranel D., Damasio H., Damasio A. Impaired recognition of emotion in facial expressions following bilateral damage to the human amygdala. Nature. 372:1994;669-6672.
3. Ayoubi T. A. Y., Van de Ven W. J. M. Regulation of gene expression by alternative promoters. Fedn Am. Socs exp. Biol. J. 10:1996;453-460.
4. Baker R. A., Herkenham M., Brady L. S. Effects of long-term treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus of rats. J. Neuroendocr. 8:1996;337-343.
5. Barden N., Reul J., Holsboer F. Do antidepressants stabilize mood through actions on the hypothalamic-pituitary-adrenocortical system? Trends Neurosci. 18:1995;6-11.
6. Beck C. H. M., Fibiger H. C. Chronic desipramine alters stress-induced behaviors and regional expression of the immediate early gene, c-fos. Pharmac. Biochem. Behav. 51:1995;331-338.
7. Behan D. P., Grigoriadis D. E., Lovenberg T., Chalmers D., Heinrichs S., Liaw C., DeSouza E. B. Neurobiology of corticotropin releasing factor (CRF) receptors and CRF-binding protein: implications for the treatment of CNS disorders. Molec. Psychiat. 1:1996;265-277.
8. 1 receptor mRNA expression. J. Neurosci. 15:1995;6340-6350.
9. Chalmers D. T., Lovenberg T. W., Grigoriadis D. E., Behan D. P., DeSouza E. B. Corticotropin-releasing factor receptors: from molecular biology to drug design. Trends pharmac. Sci. 17:1996;166-172.
10. Coplan J. D., Andrews M. W., Rosenblum L. A., Owens M. J., Friedman S., Gorman J. M., Nemeroff C. B. Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders. Proc. natn. Acad. Sci. U.S.A. 93:1996;1619-1623.
11. Cowen P. J. Serotonin receptor subtypes in depression: evidence from studies in neurocrine regulation. Clin. Neuropsychopharmac. 16:1993;S6-S18.
12. de Montigny C., Aghajanian G. K. Tricyclic antidepressants: long-term treatment increases responsivity of rat forebrain neurons to serotonin. Science. 202:1978;1303-1306.
13. De Olmos J. S. (1995) In The Human Nervous System (ed. Paxinos G.), pp. 597-710. Academic, San Diego.
14. Dinan T. G. Serotonin and the regulation of hypothalmic-pituitary-adrenal axis function. Life Sci. 58:1996;1683-1694.
15. Dryden S., Frankish H. M., Wang Q., Pickavance L., Williams G. The serotonergic agent fluoxetine reduces neuropeptide Y levels and neuropeptide Y secretion in the hypothalamus of lean and obese rats. Neuroscience. 72:1996;557-566.
16. Duncan G. E., Knapp D. J., Johnson K. B., Breese G. R. Functional classification of antidepressants based on antagonism of swim stress-induced Fos-like immunoreactivity. J. Pharmac. exp. Toxicol. 277:1996;1076-1089.
17. Eiden L. E., Hokfelt T., Brownstein M. J., Palkovits M. Vasoactive intestinal polypeptide afferents to the bed nucleus of the stria terminalis in the rat: an immunohistochemical and biochemical study. Neuroscience. 15:1985;999-1013.
18. Frazer A. Antidepressant drugs. Depression. 2:1994;1-19.
19. Gerfen C. R. The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci. 15:1992;133-139.
20. Graybiel A. M. Neurotransmitters and neuromodulators in the basal ganglia. Trends Neurosci. 13:1990;244-254.
21. Harbuz M. S., Chalmers J., DeSouza L., Lightman S. L. Stress-induced activation of CRF and c-fos mRNAs in the paraventricular nucleus are not affected by serotonin depletion. Brain Res. 609:1993;167-173.
22. Herman J. P. In situ hybridization analysis of vasopressin gene transcription in the paraventricular and supraoptic nuclei of the rat: regulation by stress and glucocorticoids. J. comp. Neurol. 363:1996;15-27.
23. Herman J. P., Schafer M., Thompson R. C., Watson S. J. Rapid regulation of corticotropin-releasing hormone gene transcription in vivo. Molec. Endocr. 93:1992;151-160.
24. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocr. Rev. 17:1996;187-205.
25. Holsboer F., Lauer C. J., Schreiber W., Krieg J. Altered hypothalmic-pituitary-adrenocortical regulation in healthy subjects at high familial risk for affective disorders. Neuroendocrinology. 62:1995;340-347.
26. Jacobs B. L., Azmitia E. C. Structure and function of the brain serotonin system. Physiol. Rev. 72:1992;165-229.
27. Kovacs K. J., Sawchenko P. E. Sequence of stress-induced alterations in indices of synaptic and transcriptional activation in parvocellular neurosecretory neurons. J. Neurosci. 16:1996;262-273.
28. Kruger L., Saporta S. and Swanson L. W. (1995) Photographic Atlas of the Rat Brain. Cambridge University Press, New York.
29. Lacroix S., Rivest S. Role of cyclo-oxygenase pathways in the stimulating influence of immune challenge on the transcription of a specific CRF receptor subtype in the rat brain. J. chem. Neuroanat. 10:1996;53-71.
30. Laflamme N., Bovetto S., Richard D., Rivest S. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus. Br. J. Pharmac. 117:1996;1021-1034.
31. 1A agonist, 8-OH-DPAT, in male rats. Brain Res. 630:1993;148-156.
32. Li Q., Brownfield M. S., Battaglia G., Cabrera T. M., Levy A. D., Rittenhouse P. A., Van De Kar L. D. Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (±)-1-(2,5-dimethoxy-4-lodophenyl)-2-aminopropane HCl (DOI). J. Pharmac. exp. Ther. 266:1993;836-844.
33. 1A agonist. J. Pharmac. exp. Toxicol. 279:1996;1035-1042.
34. Liposits Z. C., Phelix C., Paull W. K. Synaptic interaction of serotonergic axons and corticotropin releasing factor (CRF) synthesizing neurons in the hypothalamic paraventricular nucleus of the rat. Histochemistry. 86:1987;541-549.
35. Makino S., Schulkin J., Smith M. A., Pacak K., Palkovits M. and Gold P. W. (1995) Regulation of corticotropin-releasing hormone receptor messenger ribonuleic acid in the rat brain and pituitary by glucocorticoids and stress. Endocrinology 136, 4517-4525.
36. Morinobu S., Nibuya M., Duman R. S. Chronic antidepressant treatment down-regulates the induction of c-fos mRNA in response to acute stress in rat frontal cortex. Neuropsychopharmacology. 12:1995;221-228.
37. Nappi R. E., Bonneau M. J., Rivest S. Influence of the estrous cycle on c-fos and CRH gene transcription in the brain of endotoxin-challenged female rats. Neuroendocrinology. 65:1997;29-46.
38. Nemeroff C. B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Molec. Psychiat. 1:1996;336-342.
39. Nibuya M., Nestler E. J., Duman R. S. Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16:1996;2365-2372.
40. Raadsheer F. C., Hoogendijk W. J. G., Stam F. C., Tilers F. J. H., Swaab D. F. Increased numbers of corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus of depressed patients. Clin. Neuroendocr. 60:1994;436-444.
41. Rivest S., Laflamme N., Nappi R. E. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J. Neurosci. 15:1995;2680-2695.
42. Sawchenko P. E., Imaki T., Vale W. Colocalization of neuroactive substances in the endocrine hypothalamus. Ciba Found. Symp. 168:1992;16-30.
43. Sawchenko P. E., Swanson L. W., Steinbusch H. W. M. and Verhofstad A. A. J. (1983) Organization of CRF immunoreactive cells and fibres in the rat brain: immunohistochemical studies. In Corticotropin-Releasing Factor: Basic and Clinical Studies of a Neuropeptide. (eds DeSouza E. B. and Nemeroff C. B.), pp. 29-51. CRC, Florida.
44. Seasholtz A. F., Thompson R. C., Douglass J. O. Identification of a cyclic adenosine monophosphate-responsive element in the rat corticotropin-releasing hormone gene. Molec. Endocr. 2:1988;1311-1319.
45. Simmons D. M., Arriza J. L., Swanson L. W. A complete protocol for in situ hybridization of messenger RNAs in brain and other tissues with radio-labeled single-stranded RNA probes. J. Histotechnol. 12:1989;169-181.
46. Swaab D. F., Hofman M. A. Sexual differentiation of the human hypothalamus in relation to gender and sexual orientation. Trends Neurosci. 18:1995;264-270.
47. Thompson R., Seasholtz A., Douglas J. and Herbert E. (1990) Cloning and distribution of expression of the rat corticotropin-releasing factor (CRF) gene. In Corticotrophin-Releasing Factor: Brain and Clinical Studies of a Neuropeptide (eds DeSouza E. B. and Nemeroff C. B.), pp. 1-12. CRC, Florida.
48. Torres G. Fenfluramine-induced c-fos in the striatum and hypothalamus: a tract tracing study. NeuroReport. 6:1994;1679-1683.
49. Wong D. T., Bymaster F. P., Engleman E. A. Prozac (Fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication. Life Sci. 57:1995;411-441.
50. Yehuda R., Teicher M. H., Trestman R. L., Levengood R. A., Siever L. J. Cortisol regulation in posttraumatic stress disorder and major depression: a chronobiological analysis. Biol. Psychiat. 40:1996;79-88.
51. Young E. A., Akil H., Haskett R. F., Watson S. J. Evidence against changes in corticotroph CRF receptors in depressed patients. Biol. Psychiat. 37:1995;355-363.